CardioComm Solutions, Inc. to Officially Launch WebEKG at one of North America's Largest Cardiology Conferences
Victoria, B.C., March 10, 2008 – CardioComm Solutions, Inc. (TSX-V: EKG) (“CardioComm” or the “Company”) is pleased to announce that it will participate as an exhibitor during the American College of Cardiology Annual Congress, one of North America's largest cardiology meetings to be held in Chicago March 29 – April 1, 2008.
CardioComm will promote its WebEKG product to the cardiologists attending the meeting. The team on hand will include cardiologists experienced in the use of the WebEKG solution to promote the product and to provide promotional materials, including a video demonstrating the use of internet based application that can now be seen on the Company's web site.
Dr. Anatoly Langer , the Chairman of the Board, noted “This is an important step in our evolution towards the commercialization of our patented and proprietary GlobalCardio™ technology which powers the use of WebEKG and will allow inexpensive and universal use of 12 lead ECG which is the most frequently used cardiac test in the physician's office.”
“We are very excited as this opportunity will allow several of the cardiac centers and cardiac equipment distributors who have evaluated the WebEKG program to meet our medical team in person.”
About CardioComm Solutions, Inc.
CardioComm's patented and proprietary technology (GlobalCardio™) is used in products for the recording, viewing, analyzing and storing of electrocardiograms (EKGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team.
CardioComm has achieved its technical goals of improved access and communication through the development of a real-time EKG viewer. CardioComm is the first company to provide a real-time means of viewing EKGs over a network ( LAN , WAN or Internet). This tool enables EKGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as WebEKG and Global EKG Management System ( GEMS ™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.
On behalf of the Board of Directors of CardioComm Solutions, Inc.
Anatoly Langer , Chairman of the Board
For investor information, please contact :